Skip to main content

Animations

MJFF Publications

2671 - 2680 of 6255 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2022
  • 2018
  • 2024
  • 2024
  • 2022
  • 2021
  • 2021
  • 2024
  • Summary Details
    OPEN
    Title: A rapid α‐synuclein seed assay of Parkinson’s disease CSF panel shows high diagnostic accuracy
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51280
    Citation Count: 73
  • Summary Details
    OPEN
    Title: Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-020-74195-6
    Citation Count: 36
  • Summary Details
    OPEN
    Title: APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00411-x
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease
    Journal Name: European Journal of Medical Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejmg.2018.05.005
    Best OA location URL:
    Citation Count: 61
  • Summary Details
    OPEN
    Title: Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the art
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-024-01144-2
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Transcriptional programs mediating neuronal toxicity and altered glial–neuronal signaling in aDrosophilaknock-in tauopathy model
    Journal Name: Genome Research
    Publisher: Cold Spring Harbor Laboratory
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1101/gr.278576.123
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13451
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Fine mapping of the HLA locus in Parkinson’s disease in Europeans
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00231-5
    Citation Count: 56
  • Summary Details
    OPEN
    Title: GP2: The Global Parkinson's Genetics Program
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28494
    Citation Count: 129
  • Summary Details
    OPEN
    Title: Profiling Protein–Protein Interactions in the Human Brain by Refined Cofractionation Mass Spectrometry
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.3c00685
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.